Results of analgesia for patients after transurethral resection of the prostate at 108 Military Central Hospital

Tóm tắt

Objective: To evaluate the pain relief treatment for patients after transurethral prostatectomy in general and the effectiveness of patient-controlled analgesia (PCA). Subject and method: Including 124 patients undergoing transurethral resection of benign prostate hyperplasia at 108 Military Central Hospital from June 2023 to June 2024. Study design: Descriptive case series, with subgroups for comparison. Group 1 included 92 postoperative patients who received pain relief with PCA combined with conventional analgesics. Group 2 included 32 patients who received pain relief with conventional analgesics only. Result: Some characteristics of patients in groups 1 and 2: Mean age 72.4 and 72.4, BMI 22.2 and 22.3, prostate mass 64.2 and 69.5 grams, mean postoperative urethral catheterization 4.1 and 4.0 days, no statistically significant difference between the 2 groups (p>0.05). The mean VAS scores of group 1 during the 3 postoperative days were statistically significantly lower than those of group 2. Group 1 had a statistically significant lower pain level than group 2 on the first and second day after surgery. Nausea/vomiting symptoms were recorded on day 1 in groups 1 and 2 at 2.2% and 6.3%, respectively, but the difference was not statistically significant; in addition, no other adverse symptoms related to pain medication appeared in the 2 groups. Conclusion: The combination of PCA and conventional analgesics has better pain relief than regimens using only conventional analgesics. PCA is an effective and safe method in pain relief for patients after transurethral resection of the prostate.